1453526

Naltrexone Related Compound A

United States Pharmacopeia (USP) Reference Standard

• 別名: (5α)-17-(3-Butenyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride, N-(3-Butenyl)noroxymorphone hydrochloride, NIH 10458
• 実験式（ヒル表記法）: C₂₀H₂₃NO₄ · HCl
• CAS番号: 131670-05-8
• 分子量: 377.86
• MDL番号: MFCD32669881
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: naltrexone
• メーカー／製品名: USP
• 薬剤管理: USDEA Schedule II; regulated under CDSA - not available from Sigma-Aldrich Canada
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• SMILES記法: Cl.N1([C@H]2[C@]3([C@@]4([C@@H](Oc5c4c(ccc5O)C2)C(=O)CC3)CC1)O)CCC=C
• InChI: 1S/C20H23NO4.ClH/c1-2-3-9-21-10-8-19-16-12-4-5-13(22)17(16)25-18(19)14(23)6-7-20(19,24)15(21)11-12;/h2,4-5,15,18,22,24H,1,3,6-11H2;1H/t15-,18+,19+,20-;/m1./s1
• InChI Key: UMLGCEOOYPDDJJ-ITLPAZOVSA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Naltrexone Related Compound A USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Naltrexone Hydrochloride
• Naltrexone Hydrochloride Tablets

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H302,H336
• 注意書き: P261 - P264 - P270 - P271 - P301 + P312 - P304 + P340 + P312
• 危険有害性の分類: Acute Tox. 4 Oral - STOT SE 3
• ターゲットの組織: Central nervous system
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable